Varcoe Ramon L, Thomas Shannon D, Rapoza Richard J, Kum Steven
1 Department of Surgery, Prince of Wales Hospital, Sydney, Australia.
2 Faculty of Medicine, University of New South Wales, Sydney, Australia.
J Endovasc Ther. 2017 Jun;24(3):337-341. doi: 10.1177/1526602817698935. Epub 2017 Mar 20.
To describe relevant technical details with which to facilitate safe and effective use of the Absorb coronary bioresorbable vascular scaffold (BVS) in lower extremity arteries.
The Absorb BVS is a balloon-expandable, poly-l-lactide structure covered in a poly-d,l-lactide bioresorbable polymer that contains the antiproliferative drug everolimus. As a polymeric structure, it has a number of unique physical, handling, and imaging properties that may differ from metallic stents and pose a challenge to the interventionist. Attention must be paid to lesion selection, preparation, scaffold sizing, deployment, and postdilation to achieve optimal outcomes. A detailed description of these issues and deployment techniques is offered based on experience using this BVS in below-the-knee arteries.
The Absorb BVS may have application in the infrapopliteal circulation; however, its unique properties warrant careful consideration before use in the lower limb.
描述相关技术细节,以促进可吸收冠状动脉生物可吸收血管支架(BVS)在下肢动脉中的安全有效使用。
Absorb BVS是一种球囊扩张式聚左旋丙交酯结构,覆盖有含抗增殖药物依维莫司的聚消旋丙交酯生物可吸收聚合物。作为一种聚合物结构,它具有许多独特的物理、操作和成像特性,这些特性可能与金属支架不同,给介入医生带来挑战。必须注意病变选择、准备、支架尺寸确定、植入和后扩张,以实现最佳效果。基于在膝下动脉使用这种BVS的经验,对这些问题和植入技术进行了详细描述。
Absorb BVS可能适用于腘动脉以下循环;然而,其独特的特性在用于下肢之前需要仔细考虑。